Fixed ratio combination of basal insulin and GLP-1 receptor agonist

Insulin icodec with semaglutide 0.114 to 40 mg injection

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ICOSEMA_SC_0p114-40MG_OTHER

Mechanism: IDegLira; iGlarLixi; IcoSema
Trials: 0
Participants in these arms: 0

All doses pooled: Insulin icodec with semaglutide injection
Insulin icodec and semaglutide (IcoSema) subcutaneous once weekly titrated
Insulin icodec with semaglutide 0.5 to 175 mg injection

Insulin icodec with semaglutide 0.114 to 40 mg injection

Related

Trials